Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
NCT03514381
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma
Interventions
DRUG:
Patients starting a treatment with Doxorubicin and Ifosfamide
Sponsor
Institut Claudius Regaud